less than both equally Drake’s and Lynch’s styles, the cost of deleterious mutations is what drives mutation rates down (Drake 1991; Lynch 2010; Sung et al. 2012). consequently, under both products, a rise in the average price of mutations would result in a minimize in mutation premiums. To examine this, Drake examined mutation fees of thermoph